Am. J. Respir. Crit. Care Med., Vol 151, No. 4, Apr 1995, 1233-1238.
Granulocyte-macrophage colony stimulating factor and Pneumocystis carinii pneumonia in mice
JF Mandujano, NB D'Souza, S Nelson, WR Summer, RC Beckerman and JE Shellito
Section of Pulmonary and Critical Care Medicine, Louisiana State University Medical Center, New Orleans 70112.
We hypothesized that therapy with granulocyte-macrophage colony stimulating
factor (GM-CSF) would decrease intensity of murine Pneumocystis carinii
pneumonia by upregulating alveolar macrophage function. Mice were depleted
of CD4+ T lymphocytes and then inoculated intratracheally with P. carinii.
Four weeks later, they received recombinant murine GM-CSF (rmGM-CSF) 5
micrograms/d subcutaneously for 7 and 14 d. At the end of therapy lung
tissue was scored for intensity of P. carinii infection by silver
methenamine stain and for inflammation by hematoxylin-eosin stain. We found
that rmGM-CSF therapy significant decreased the intensity scores of PCP
infection in comparison to control mice (1.88 +/- 0.47 vs 3.06 +/- 0.12, p
< 0.001). Inflammation scores were not significantly different in the
rmGM-CSF group compared with the control group (1.83 +/- 0.47 vs 2.83 +/-
0.67). Alveolar macrophages from mice treated with rmGM-CSF released
significantly more tumor necrosis factor-alpha (TNF-alpha) than cells from
control mice after in vitro stimulation with lipopolysaccharide (LPS) alone
(2.65 +/- 0.30 vs 1.45 +/- 0.26 ng/ml, p = 0.01) or with LPS plus murine
recombinant interferon-gamma (4.16 +/- 0.51 vs 2.25 +/- 0.34 ng/ml, p =
0.01). We conclude that GM-CSF therapy reduces the intensity of PCP and
this effect is associated with an enhanced alveolar macrophage TNF-alpha
production.
This article has been cited by other articles:

|
 |

|
 |
 
F. McAllister, S. Ruan, C. Steele, M. Zheng, L. McKinley, L. Ulrich, L. Marrero, J. E. Shellito, and J. K. Kolls
CXCR3 and IFN Protein-10 in Pneumocystis Pneumonia
J. Immunol.,
August 1, 2006;
177(3):
1846 - 1854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Lasbury, P. J. Durant, C. A. Ray, D. Tschang, R. Schwendener, and C.-H. Lee
Suppression of Alveolar Macrophage Apoptosis Prolongs Survival of Rats and Mice with Pneumocystis Pneumonia.
J. Immunol.,
June 1, 2006;
176(11):
6443 - 6453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. McAllister, C. Steele, M. Zheng, J. E. Shellito, and J. K. Kolls
In Vitro Effector Activity of Pneumocystis murina-Specific T-Cytotoxic-1 CD8+ T Cells: Role of Granulocyte-Macrophage Colony-Stimulating Factor
Infect. Immun.,
November 1, 2005;
73(11):
7450 - 7457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Qureshi, K. M. Empey, and B. A. Garvy
Modulation of Proinflammatory Responses to Pneumocystis carinii f. sp. muris in Neonatal Mice by Granulocyte-Macrophage Colony-Stimulating Factor and IL-4: Role of APCs
J. Immunol.,
January 1, 2005;
174(1):
441 - 448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Lasbury, P. Lin, D. Tschang, P. J. Durant, and C.-H. Lee
Effect of Bronchoalveolar Lavage Fluid from Pneumocystis carinii- Infected Hosts on Phagocytic Activity of Alveolar Macrophages
Infect. Immun.,
April 1, 2004;
72(4):
2140 - 2147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Mc Allister, C. Steele, M. Zheng, E. Young, J. E. Shellito, L. Marrero, and J. K. Kolls
T Cytotoxic-1 CD8+ T Cells Are Effector Cells against Pneumocystis in Mice
J. Immunol.,
January 15, 2004;
172(2):
1132 - 1138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Lasbury, X. Tang, P. J. Durant, and C.-H. Lee
Effect of Transcription Factor GATA-2 on Phagocytic Activity of Alveolar Macrophages from Pneumocystis carinii-Infected Hosts
Infect. Immun.,
September 1, 2003;
71(9):
4943 - 4952.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ruan, C. Tate, J. J. Lee, T. Ritter, J. K. Kolls, and J. E. Shellito
Local Delivery of the Viral Interleukin-10 Gene Suppresses Tissue Inflammation in Murine Pneumocystis carinii Infection
Infect. Immun.,
November 1, 2002;
70(11):
6107 - 6113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Gilmartin and H. Koziel
Pneumocystis Carinii Pneumonia in Adult Non-HIV Disorders
J Intensive Care Med,
November 1, 2002;
17(6):
283 - 301.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Deepe Jr. and R. Gibbons
Recombinant Murine Granulocyte-Macrophage Colony-Stimulating Factor Modulates the Course of Pulmonary Histoplasmosis in Immunocompetent and Immunodeficient Mice
Antimicrob. Agents Chemother.,
December 1, 2000;
44(12):
3328 - 3336.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. J. Martin II and R. Pasula
Role of Alveolar Macrophages in Host Defense against Pneumocystis carinii
Am. J. Respir. Cell Mol. Biol.,
October 1, 2000;
23(4):
434 - 435.
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Paine III, A. M. Preston, S. Wilcoxen, H. Jin, B. B. Siu, S. B. Morris, J. A. Reed, G. Ross, J. A. Whitsett, and J. M. Beck
Granulocyte-Macrophage Colony-Stimulating Factor in the Innate Immune Response to Pneumocystis carinii Pneumonia in Mice
J. Immunol.,
March 1, 2000;
164(5):
2602 - 2609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Coffey, S. M. Phare, S. Cinti, M. Peters-Golden, and P. H. Kazanjian
Granulocyte-Macrophage Colony-Stimulating Factor Upregulates Reduced 5-Lipoxygenase Metabolism in Peripheral Blood Monocytes and Neutrophils in Acquired Immunodeficiency Syndrome
Blood,
December 1, 1999;
94(11):
3897 - 3905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Walzer
Immunological Features of Pneumocystis carinii Infection in Humans
Clin. Vaccine Immunol.,
March 1, 1999;
6(2):
149 - 155.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Kolls, S. Habetz, M. K. Shean, C. Vazquez, J. A. Brown, D. Lei, P. Schwarzenberger, P. Ye, S. Nelson, W. R. Summer, et al.
IFN-{gamma} and CD8+ T Cells Restore Host Defenses Against Pneumocystis carinii in Mice Depleted of CD4+ T Cells
J. Immunol.,
March 1, 1999;
162(5):
2890 - 2894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Worgall, R. Singh, P. L. Leopold, R. J. Kaner, N. R. Hackett, N. Topf, M. A.S. Moore, and R. G. Crystal
Selective Expansion of Alveolar Macrophages In Vivo by Adenovirus-Mediated Transfer of the Murine Granulocyte-Macrophage Colony-Stimulating Factor cDNA
Blood,
January 15, 1999;
93(2):
655 - 666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Rudmann, A. M. Preston, M. W. Moore, and J. M. Beck
Susceptibility to Pneumocystis carinii in Mice Is Dependent on Simultaneous Deletion of IFN-{gamma} and Type 1 and 2 TNF Receptor Genes
J. Immunol.,
July 1, 1998;
161(1):
360 - 366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. W. Wright, C. J. Johnston, A. G. Harmsen, and J. N. Finkelstein
Analysis of Cytokine mRNA Profiles in the Lungs of Pneumocystis carinii-infected Mice
Am. J. Respir. Cell Mol. Biol.,
October 1, 1997;
17(4):
491 - 500.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1995 American Thoracic Society
|
|
|